AC
BSX icon

AlphaCore Capital’s Boston Scientific BSX Stock Holding History

AlphaCore Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$597K Buy
13,995
+7,461
+114% +$405K 0.01% 610
2026
Q1 		$410K Buy
6,534
+439
+7% +$35.1K 0.01% 603
2025
Q4 		$581K Buy
6,095
+1,145
+23% +$112K 0.01% 569
2025
Q3 		$483K Buy
4,950
+2,518
+104% +$261K 0.02% 463
2025
Q2 		$261K Buy
+2,432
New +$246K 0.01% 514

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AlphaCore Capital's BSX Position: Q2 2026 in Review

AlphaCore Capital increased its Boston Scientific (BSX) stake by 114% in Q2 2026, buying an estimated $405K and bringing the position to 13,995 shares worth $597K. The position accounts for 0.01% of the portfolio, ranked #610.

AlphaCore Capital first reported a position in BSX in Q2 2025 and has held it in 5 quarters since. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • AlphaCore Capital held 13,995 shares of Boston Scientific worth $597K as of Q2 2026.
  • AlphaCore Capital bought 7,461 Boston Scientific shares in Q2 2026, an estimated $405K.
  • Boston Scientific made up 0.01% of AlphaCore Capital's portfolio in Q2 2026, its #610 holding.
  • AlphaCore Capital first reported a position in Boston Scientific in Q2 2025 and has held it in 5 quarters since.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.